Tris Pharma Inc RX
FDA Approved Drugs

Tris Pharma Inc RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 23
  • Latest Approval Date May 24, 2024
  • Data Source FDA
  • First Approval Date Jul 23, 2010
All
45
View
Discontinued
20
View
OTC
2
View
RX
23
View
Company Overview

Company

Tris Pharma Inc RX

Country

U.S.A

Website

Visit Website

Email

Info@trispharma.com

Social Profiles

Company Snapshot

Tris Pharma Inc RX

Brunswick Business Park, 2033 Route 130, Suite D, Monmouth Junction, NJ 08852,

U.S.A

www.trispharma.com/ Info@trispharma.com View on Map
FDA Approved Drug Records ( 23 records )
2024
25 Apr
RX Application: 217813

Drug Name

DEFLAZACORT

Product Number

1

Dosage Form

-

Strength

22.75MG/ML

Approval Date

2024-04-25

217813 / 1

Active Ingredient

DEFLAZACORT

Application Number

217813

Product Number

1

Dosage Form

-

Strength

22.75MG/ML

Approval Date

2024-04-25

Regulatory Status

RX

2016
26 Aug
RX Application: 207901

Drug Name

DEXMETHYLPHENIDATE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2016-08-26

207901 / 1

Active Ingredient

DEXMETHYLPHENIDATE HYDROCHLORIDE

Application Number

207901

Product Number

1

Dosage Form

-

Strength

2.5MG

Approval Date

2016-08-26

Regulatory Status

RX

2016
26 Aug
RX Application: 207901

Drug Name

DEXMETHYLPHENIDATE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2016-08-26

207901 / 2

Active Ingredient

DEXMETHYLPHENIDATE HYDROCHLORIDE

Application Number

207901

Product Number

2

Dosage Form

-

Strength

5MG

Approval Date

2016-08-26

Regulatory Status

RX

2016
26 Aug
RX Application: 207901

Drug Name

DEXMETHYLPHENIDATE HYDROCHLORIDE

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2016-08-26

207901 / 3

Active Ingredient

DEXMETHYLPHENIDATE HYDROCHLORIDE

Application Number

207901

Product Number

3

Dosage Form

-

Strength

10MG

Approval Date

2016-08-26

Regulatory Status

RX

2013
29 May
RX Application: 203644

Drug Name

DEXTROAMPHETAMINE SULFATE

Product Number

1

Dosage Form

-

Strength

5MG/5ML

Approval Date

2013-05-29

203644 / 1

Active Ingredient

DEXTROAMPHETAMINE SULFATE

Application Number

203644

Product Number

1

Dosage Form

-

Strength

5MG/5ML

Approval Date

2013-05-29

Regulatory Status

RX

2015
19 Oct
RX Application: 208147

Drug Name

DYANAVEL XR

Product Number

1

Dosage Form

-

Strength

2MG/ML;EQ 0.5MG BASE/ML

Approval Date

2015-10-19

208147 / 1

Active Ingredient

AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

Application Number

208147

Product Number

1

Dosage Form

-

Strength

2MG/ML;EQ 0.5MG BASE/ML

Approval Date

2015-10-19

Regulatory Status

RX

2021
04 Nov
RX Application: 210526

Drug Name

DYANAVEL XR 10

Product Number

2

Dosage Form

-

Strength

8MG;EQ 2MG BASE

Approval Date

2021-11-04

210526 / 2

Active Ingredient

AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

Application Number

210526

Product Number

2

Dosage Form

-

Strength

8MG;EQ 2MG BASE

Approval Date

2021-11-04

Regulatory Status

RX

2021
04 Nov
RX Application: 210526

Drug Name

DYANAVEL XR 15

Product Number

3

Dosage Form

-

Strength

12MG;EQ 3MG BASE

Approval Date

2021-11-04

210526 / 3

Active Ingredient

AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

Application Number

210526

Product Number

3

Dosage Form

-

Strength

12MG;EQ 3MG BASE

Approval Date

2021-11-04

Regulatory Status

RX

2021
04 Nov
RX Application: 210526

Drug Name

DYANAVEL XR 20

Product Number

4

Dosage Form

-

Strength

16MG;EQ 4MG BASE

Approval Date

2021-11-04

210526 / 4

Active Ingredient

AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

Application Number

210526

Product Number

4

Dosage Form

-

Strength

16MG;EQ 4MG BASE

Approval Date

2021-11-04

Regulatory Status

RX

2021
04 Nov
RX Application: 210526

Drug Name

DYANAVEL XR 5

Product Number

1

Dosage Form

-

Strength

4MG;EQ 1MG BASE

Approval Date

2021-11-04

210526 / 1

Active Ingredient

AMPHETAMINE; AMPHETAMINE ASPARTATE/DEXTROAMPHETAMINE SULFATE

Application Number

210526

Product Number

1

Dosage Form

-

Strength

4MG;EQ 1MG BASE

Approval Date

2021-11-04

Regulatory Status

RX

2013
27 Mar
RX Application: 202214

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

1

Dosage Form

-

Strength

325MG;5MG

Approval Date

2013-03-27

202214 / 1

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

202214

Product Number

1

Dosage Form

-

Strength

325MG;5MG

Approval Date

2013-03-27

Regulatory Status

RX

2013
27 Mar
RX Application: 202214

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

2

Dosage Form

-

Strength

325MG;7.5MG

Approval Date

2013-03-27

202214 / 2

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

202214

Product Number

2

Dosage Form

-

Strength

325MG;7.5MG

Approval Date

2013-03-27

Regulatory Status

RX

2013
27 Mar
RX Application: 202214

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

3

Dosage Form

-

Strength

325MG;10MG

Approval Date

2013-03-27

202214 / 3

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

202214

Product Number

3

Dosage Form

-

Strength

325MG;10MG

Approval Date

2013-03-27

Regulatory Status

RX

2016
15 Mar
RX Application: 202214

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

4

Dosage Form

-

Strength

300MG;5MG

Approval Date

2016-03-15

202214 / 4

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

202214

Product Number

4

Dosage Form

-

Strength

300MG;5MG

Approval Date

2016-03-15

Regulatory Status

RX

2016
15 Mar
RX Application: 202214

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

5

Dosage Form

-

Strength

300MG;7.5MG

Approval Date

2016-03-15

202214 / 5

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

202214

Product Number

5

Dosage Form

-

Strength

300MG;7.5MG

Approval Date

2016-03-15

Regulatory Status

RX

2016
15 Mar
RX Application: 202214

Drug Name

HYDROCODONE BITARTRATE AND ACETAMINOPHEN

Product Number

6

Dosage Form

-

Strength

300MG;10MG

Approval Date

2016-03-15

202214 / 6

Active Ingredient

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Application Number

202214

Product Number

6

Dosage Form

-

Strength

300MG;10MG

Approval Date

2016-03-15

Regulatory Status

RX

2010
01 Oct
RX Application: 91632

Drug Name

HYDROCODONE POLISTIREX AND CHLORPHENIRAMINE POLISTIREX

Product Number

1

Dosage Form

-

Strength

EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML

Approval Date

2010-10-01

91632 / 1

Active Ingredient

CHLORPHENIRAMINE POLISTIREX; HYDROCODONE POLISTIREX

Application Number

91632

Product Number

1

Dosage Form

-

Strength

EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML

Approval Date

2010-10-01

Regulatory Status

RX

2010
23 Jul
RX Application: 91601

Drug Name

METHYLPHENIDATE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG/5ML

Approval Date

2010-07-23

91601 / 1

Active Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Application Number

91601

Product Number

1

Dosage Form

-

Strength

5MG/5ML

Approval Date

2010-07-23

Regulatory Status

RX

2010
23 Jul
RX Application: 91601

Drug Name

METHYLPHENIDATE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

10MG/5ML

Approval Date

2010-07-23

91601 / 2

Active Ingredient

METHYLPHENIDATE HYDROCHLORIDE

Application Number

91601

Product Number

2

Dosage Form

-

Strength

10MG/5ML

Approval Date

2010-07-23

Regulatory Status

RX

2015
12 May
RX Application: 203518

Drug Name

MORPHINE SULFATE

Product Number

2

Dosage Form

-

Strength

100MG/5ML

Approval Date

2015-05-12

203518 / 2

Active Ingredient

MORPHINE SULFATE

Application Number

203518

Product Number

2

Dosage Form

-

Strength

100MG/5ML

Approval Date

2015-05-12

Regulatory Status

RX

2024
24 May
RX Application: 217645

Drug Name

ONYDA XR

Product Number

1

Dosage Form

-

Strength

0.1MG/ML

Approval Date

2024-05-24

217645 / 1

Active Ingredient

CLONIDINE HYDROCHLORIDE

Application Number

217645

Product Number

1

Dosage Form

-

Strength

0.1MG/ML

Approval Date

2024-05-24

Regulatory Status

RX

2012
12 Dec
RX Application: 79059

Drug Name

RISPERIDONE

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2012-12-12

79059 / 1

Active Ingredient

RISPERIDONE

Application Number

79059

Product Number

1

Dosage Form

-

Strength

1MG/ML

Approval Date

2012-12-12

Regulatory Status

RX

2012
15 Jun
RX Application: 91586

Drug Name

THEOPHYLLINE

Product Number

1

Dosage Form

-

Strength

80MG/15ML

Approval Date

2012-06-15

91586 / 1

Active Ingredient

THEOPHYLLINE

Application Number

91586

Product Number

1

Dosage Form

-

Strength

80MG/15ML

Approval Date

2012-06-15

Regulatory Status

RX

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    45 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
23 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

DEFLAZACORT

Application Number

217813

Product Number

1

Active Ingredient

DEFLAZACORT

Dosage Form

-

Strength

22.75MG/ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit